<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03769207</url>
  </required_header>
  <id_info>
    <org_study_id>1.2</org_study_id>
    <secondary_id>48787</secondary_id>
    <nct_id>NCT03769207</nct_id>
  </id_info>
  <brief_title>Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias</brief_title>
  <official_title>Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Apple Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Apple Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-marketing study is conducted to characterize the ability of Apple Watch rhythm
      analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical
      evaluation among users who contact AppleCare.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 8, 2018</start_date>
  <completion_date type="Actual">August 20, 2019</completion_date>
  <primary_completion_date type="Actual">July 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial Fibrillation or Atrial Flutter (AF) of at least 30 seconds duration</measure>
    <time_frame>During ambulatory ECG Monitoring (up to 8 days)</time_frame>
    <description>Detected on ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arrhythmias other than AF</measure>
    <time_frame>During ambulatory ECG Monitoring (up to 8 days)</time_frame>
    <description>Detected on an ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported contact with healthcare provider</measure>
    <time_frame>Within 60 days following enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>Ambulatory ECG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ambulatory ECG</intervention_name>
    <description>Eligible participants are asked to wear the ambulatory ECG monitor</description>
    <arm_group_label>Ambulatory ECG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Possession of the following at time of eligibility screening:

               -  iPhone (5s or later) with iOS version 12.1.1 or later defined as iPhone model/iOS
                  version used to complete screening eligibility.

               -  Apple Watch (Series 1-4) with watchOS version 5.1.2 or later defined as Apple
                  Watch model/watchOS paired with iPhone used to complete screening eligibility

          2. At least one of the following by self-report before consent:

               -  Irregular Rhythm Notification

               -  ECG app classification of Atrial Fibrillation

               -  ECG app classification of Inconclusive defined as &quot;Inconclusive,&quot; &quot;Heart Rate
                  Over 120,&quot; or &quot;Heart Rate Under 50&quot;

          3. Age â‰¥ 22 years at time of eligibility screening

          4. Current resident of the United States at time of eligibility screening, and will
             reside in the United States for the length of the study

          5. Proficient in written and spoken English

          6. Valid phone number associated with iPhone, ascertained from self-report

          7. Valid email address, ascertained from self-report

        Exclusion Criteria:

          1. Shared iCloud account

          2. Shared AppleWatch
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco V Perez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Minang (Mintu) Turakhia, MD, MAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>December 6, 2018</study_first_submitted>
  <study_first_submitted_qc>December 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2018</study_first_posted>
  <last_update_submitted>October 2, 2019</last_update_submitted>
  <last_update_submitted_qc>October 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Marco Perez</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine (Cardiovascular Medicine)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

